Carbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes
Creators
- 1. Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, Heidelberg (Germany)
- 2. Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, Heidelberg (Germany)
- 3. National Center for Tumor diseases (NCT), Im Neuenheimer Feld 460, Heidelberg (Germany)
- 4. Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg (Germany)
- 5. Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, Heidelberg (Germany)
- 6. Department of Radiation Oncology, Freiburg University Medical Center, Robert-Koch-Straße 3, Freiburg im Breisgau (Germany)
- 7. German Cancer Consortium (DKTK), partner site Heidelberg (Germany)
- 8. Department of Radiation Oncology, Municipal Hospital Karlsruhe gGmbH, Moltkestraße 90, Karlsruhe (Germany)
Description
To date, only few data exist on mechanisms underlying the human papillomavirus (HPV)-associated irradiation response. It has been suggested, that the viral E2 gene plays an important role in that context. The aim of the current study is to compare the effect of photon- and carbon-ion (12C)-radiation therapy (RT) on cells with different HPV and E2 gene status. We hypothesized that 12C-RT might overcome the radioresistance of E2 gene-disrupted cells. We analyzed four different cell lines that differed in HPV status or E2 gene status. Cells were irradiated with either photons or 12C. Clonogenic survival, cell cycle and expression of Rb and p53 were analyzed. Radiosensitivity seemed to be dependent on E2 gene status and type of RT. 12C-RT led to lower surviving fractions, indicating higher radiosensitivity even in cells with disrupted E2 gene. The observed relative biological effectiveness (RBE) of 12C-RT for C33a/Caski and W12/S12 was 1.3/4 and 2.7/2.5, respectively. Cell cycle regulation after both photon- and 12C-RT was dependent on HPV status and on E2 gene status. Furthermore, the effect of RT on expression of p53 and Rb seemed to be dependent on E2 gene status and type of RT. We showed that 12C-RT overcomes HPV-integration induced radioresistance. The effect of RT on cell cycle regulation as well as on expression of p53 and Rb seemed to be dependent on HPV status, E2 gene status and type of RT. Differences in Rb expression and cell cycle regulation may play a role for enhanced radiosensitivity to 12C-RT of cells with disrupted E2 gene.
Availability note (English)
Available from http://dx.doi.org/10.1093/jrr/rrz048; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805985Additional details
Identifiers
Publishing Information
- Journal Title
- Journal of Radiation Research
- Journal Volume
- 60
- Journal Issue
- 5
- Journal Page Range
- p. 564-572
- ISSN
- 0449-3060
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 54118595
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- CARBON 12; CARCINOMAS; CELL CYCLE; DNA DAMAGES; ESTRADIOL; GENES; ION BEAM THERAPY; KERATIN; PHOTONS; RADIOSENSITIVITY; RBE; UROGENITAL SYSTEM DISEASES; VIRUSES
- Descriptors DEC
- BOSONS; CARBON ISOTOPES; DISEASES; ELEMENTARY PARTICLES; ESTRANES; ESTROGENS; EVEN-EVEN NUCLEI; EXTERNAL BEAM RADIATION THERAPY; HORMONES; HYDROXY COMPOUNDS; ISOTOPES; LIGHT NUCLEI; MASSLESS PARTICLES; MEDICINE; MICROORGANISMS; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ORGANIC COMPOUNDS; PARASITES; PROTEINS; RADIOLOGY; RADIOTHERAPY; SCLEROPROTEINS; SENSITIVITY; STABLE ISOTOPES; STEROID HORMONES; STEROIDS; THERAPY
Optional Information
- Copyright
- Copyright (c) The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.
- Notes
- PMCID: PMC6805985; PMID: 31322705; PMID: 31322705; PUBLISHER-ID: rrz048; OAI: oai:pubmedcentral.nih.gov:6805985